King's College London

Research portal

Biomarkers of immune tolerance in liver transplantation

Research output: Contribution to journalArticlepeer-review

Julien Vionnet, Alberto Sánchez-Fueyo

Original languageEnglish
JournalHuman Immunology
Early online date17 Feb 2018
DOIs
Accepted/In press13 Feb 2018
E-pub ahead of print17 Feb 2018

Documents

King's Authors

Abstract

The liver exhibits intrinsic immune tolerogenic properties that contribute to a unique propensity toward spontaneous acceptance when transplanted, both in animal models and in humans. Thus, in contrast to what happens after transplantation of other solid organs, several years following liver transplantation a significant subset of patients are capable of maintaining normal allograft function with histological integrity in the absence of immunosuppressive drug treatment. Significant efforts have been put into identifying sensitive and specific biomarkers of tolerance in order to stratify liver transplant recipients according to their need for immunosuppressive medication and their likelihood of being able to completely discontinue it. These biomarkers are currently being validated in prospective clinical trials of immunosuppression withdrawal both in Europe and in the United States. These studies have the potential to transform the clinical management of liver transplant recipients by mitigating, at least in part, the burden of lifelong immunosuppression.

Download statistics

No data available

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454